CDC’s Advisory Committee on Immunization Practices (ACIP) has recommended the Janssen (NYSE:JNJ) COVID-19 vaccine booster at least two months after the initial dose.
The committee also recommended a booster of the Moderna’s (NSDQ:MRNA) COVID-19 vaccine for people 65 and a handful of other demographics. Also eligible for boosters are individuals at least 18 who are immunocompromised and those who have frequent occupational or institutional exposure to SARS-CoV-2.
The recommendation for the Moderna boosters pertains to the 50-µg dose level, which is half the level used in the primary series.
CDC Director Dr. Rochelle Walensky will now decide whether to accept or alter the ACIP recommendations. For the Pfizer-BioNTech booster, Walensky opted to support boosters for a larger segment of people than the ACIP had recommended.
Walensky is likely to issue a final decision in the coming days.
The CDC advisors also recommended allowing Americans to choose between booster doses from Pfizer-BioNTech, Moderna and Janssen.